Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer

Sharanjot Saini, Shahana Majid, Varahram Shahryari, Z. Laura Tabatabai, Sumit Arora, Soichiro Yamamura, Yuichiro Tanaka, Rajvir Dahiya, Guoren Deng

Research output: Contribution to journalArticle

Abstract

Genomic studies suggest that deletions at chromosome (chr) 5q region (particularly chr5q14-q23) are frequent in prostate cancer, implicating this region in prostate carcinogenesis. However, the genes within this region are largely unknown. Here, we report for the first time the widespread attenuation of miR-3607, an miRNA gene located at chr5q14 region, in prostate cancer. Expression analyses of miR-3607 in a clinical cohort of prostate cancer specimens showed that miR-3607 is significantly attenuated and low miR-3607 expression is correlated with tumor progression and poor survival outcome in prostate cancer. Our analyses suggest that miR-3607 expression may be a clinically significant parameter with an associated diagnostic potential. We examined the functional significance of miR-3607 in prostate cancer cell lines and found that miR-3607 overexpression led to significantly decreased proliferation, apoptosis induction, and decreased invasiveness. Furthermore, our results suggest that miR-3607 directly represses oncogenic SRC family kinases LYN and SRC in prostate cancer. In view of our results, we propose that miR-3607 plays a tumor-suppressive role in prostate cancer by regulating SRC kinases that in turn regulates prostate carcinogenesis. To our knowledge, this is the first report that: (i) identifies a novel role for miR-3607 located in a frequently deleted region of prostate cancer and (ii) defines novel miRNA-mediated regulation of SRC kinases in prostate cancer. Because SRC kinases play a central role in prostate cancer progression and metastasis and are attractive targets, this study has potential implications in the design of better therapeutic modalities for prostate cancer management.

Original languageEnglish (US)
Pages (from-to)1952-1963
Number of pages12
JournalMolecular cancer therapeutics
Volume13
Issue number7
DOIs
StatePublished - Jul 2014
Externally publishedYes

Fingerprint

MicroRNAs
Prostatic Neoplasms
Phosphotransferases
Prostate
Carcinogenesis
Chromosome Deletion
Genes
Neoplasms
Apoptosis
Neoplasm Metastasis
Cell Line

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Saini, S., Majid, S., Shahryari, V., Tabatabai, Z. L., Arora, S., Yamamura, S., ... Deng, G. (2014). Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Molecular cancer therapeutics, 13(7), 1952-1963. https://doi.org/10.1158/1535-7163.MCT-14-0017

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. / Saini, Sharanjot; Majid, Shahana; Shahryari, Varahram; Tabatabai, Z. Laura; Arora, Sumit; Yamamura, Soichiro; Tanaka, Yuichiro; Dahiya, Rajvir; Deng, Guoren.

In: Molecular cancer therapeutics, Vol. 13, No. 7, 07.2014, p. 1952-1963.

Research output: Contribution to journalArticle

Saini, S, Majid, S, Shahryari, V, Tabatabai, ZL, Arora, S, Yamamura, S, Tanaka, Y, Dahiya, R & Deng, G 2014, 'Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer', Molecular cancer therapeutics, vol. 13, no. 7, pp. 1952-1963. https://doi.org/10.1158/1535-7163.MCT-14-0017
Saini, Sharanjot ; Majid, Shahana ; Shahryari, Varahram ; Tabatabai, Z. Laura ; Arora, Sumit ; Yamamura, Soichiro ; Tanaka, Yuichiro ; Dahiya, Rajvir ; Deng, Guoren. / Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. In: Molecular cancer therapeutics. 2014 ; Vol. 13, No. 7. pp. 1952-1963.
@article{4e1225c0e56a486ca1d6a2e605149ab5,
title = "Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer",
abstract = "Genomic studies suggest that deletions at chromosome (chr) 5q region (particularly chr5q14-q23) are frequent in prostate cancer, implicating this region in prostate carcinogenesis. However, the genes within this region are largely unknown. Here, we report for the first time the widespread attenuation of miR-3607, an miRNA gene located at chr5q14 region, in prostate cancer. Expression analyses of miR-3607 in a clinical cohort of prostate cancer specimens showed that miR-3607 is significantly attenuated and low miR-3607 expression is correlated with tumor progression and poor survival outcome in prostate cancer. Our analyses suggest that miR-3607 expression may be a clinically significant parameter with an associated diagnostic potential. We examined the functional significance of miR-3607 in prostate cancer cell lines and found that miR-3607 overexpression led to significantly decreased proliferation, apoptosis induction, and decreased invasiveness. Furthermore, our results suggest that miR-3607 directly represses oncogenic SRC family kinases LYN and SRC in prostate cancer. In view of our results, we propose that miR-3607 plays a tumor-suppressive role in prostate cancer by regulating SRC kinases that in turn regulates prostate carcinogenesis. To our knowledge, this is the first report that: (i) identifies a novel role for miR-3607 located in a frequently deleted region of prostate cancer and (ii) defines novel miRNA-mediated regulation of SRC kinases in prostate cancer. Because SRC kinases play a central role in prostate cancer progression and metastasis and are attractive targets, this study has potential implications in the design of better therapeutic modalities for prostate cancer management.",
author = "Sharanjot Saini and Shahana Majid and Varahram Shahryari and Tabatabai, {Z. Laura} and Sumit Arora and Soichiro Yamamura and Yuichiro Tanaka and Rajvir Dahiya and Guoren Deng",
year = "2014",
month = "7",
doi = "10.1158/1535-7163.MCT-14-0017",
language = "English (US)",
volume = "13",
pages = "1952--1963",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer

AU - Saini, Sharanjot

AU - Majid, Shahana

AU - Shahryari, Varahram

AU - Tabatabai, Z. Laura

AU - Arora, Sumit

AU - Yamamura, Soichiro

AU - Tanaka, Yuichiro

AU - Dahiya, Rajvir

AU - Deng, Guoren

PY - 2014/7

Y1 - 2014/7

N2 - Genomic studies suggest that deletions at chromosome (chr) 5q region (particularly chr5q14-q23) are frequent in prostate cancer, implicating this region in prostate carcinogenesis. However, the genes within this region are largely unknown. Here, we report for the first time the widespread attenuation of miR-3607, an miRNA gene located at chr5q14 region, in prostate cancer. Expression analyses of miR-3607 in a clinical cohort of prostate cancer specimens showed that miR-3607 is significantly attenuated and low miR-3607 expression is correlated with tumor progression and poor survival outcome in prostate cancer. Our analyses suggest that miR-3607 expression may be a clinically significant parameter with an associated diagnostic potential. We examined the functional significance of miR-3607 in prostate cancer cell lines and found that miR-3607 overexpression led to significantly decreased proliferation, apoptosis induction, and decreased invasiveness. Furthermore, our results suggest that miR-3607 directly represses oncogenic SRC family kinases LYN and SRC in prostate cancer. In view of our results, we propose that miR-3607 plays a tumor-suppressive role in prostate cancer by regulating SRC kinases that in turn regulates prostate carcinogenesis. To our knowledge, this is the first report that: (i) identifies a novel role for miR-3607 located in a frequently deleted region of prostate cancer and (ii) defines novel miRNA-mediated regulation of SRC kinases in prostate cancer. Because SRC kinases play a central role in prostate cancer progression and metastasis and are attractive targets, this study has potential implications in the design of better therapeutic modalities for prostate cancer management.

AB - Genomic studies suggest that deletions at chromosome (chr) 5q region (particularly chr5q14-q23) are frequent in prostate cancer, implicating this region in prostate carcinogenesis. However, the genes within this region are largely unknown. Here, we report for the first time the widespread attenuation of miR-3607, an miRNA gene located at chr5q14 region, in prostate cancer. Expression analyses of miR-3607 in a clinical cohort of prostate cancer specimens showed that miR-3607 is significantly attenuated and low miR-3607 expression is correlated with tumor progression and poor survival outcome in prostate cancer. Our analyses suggest that miR-3607 expression may be a clinically significant parameter with an associated diagnostic potential. We examined the functional significance of miR-3607 in prostate cancer cell lines and found that miR-3607 overexpression led to significantly decreased proliferation, apoptosis induction, and decreased invasiveness. Furthermore, our results suggest that miR-3607 directly represses oncogenic SRC family kinases LYN and SRC in prostate cancer. In view of our results, we propose that miR-3607 plays a tumor-suppressive role in prostate cancer by regulating SRC kinases that in turn regulates prostate carcinogenesis. To our knowledge, this is the first report that: (i) identifies a novel role for miR-3607 located in a frequently deleted region of prostate cancer and (ii) defines novel miRNA-mediated regulation of SRC kinases in prostate cancer. Because SRC kinases play a central role in prostate cancer progression and metastasis and are attractive targets, this study has potential implications in the design of better therapeutic modalities for prostate cancer management.

UR - http://www.scopus.com/inward/record.url?scp=84904170727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904170727&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-14-0017

DO - 10.1158/1535-7163.MCT-14-0017

M3 - Article

C2 - 24817628

AN - SCOPUS:84904170727

VL - 13

SP - 1952

EP - 1963

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 7

ER -